MDA SPACE LTD (MDA.CA) Stock Fundamental Analysis
Canada - Toronto Stock Exchange - TSX:MDA - CA55293N1096 - Common Stock
24.41 CAD
-0.49 (-1.97%)
Taking everything into account, MDA scores 6 out of 10 in our fundamental rating. MDA was compared to 11 industry peers in the Aerospace & Defense industry. While MDA has a great profitability rating, there are some minor concerns on its financial health. MDA is showing excellent growth while it is valued at reasonable prices. Keep and eye on this one! With these ratings, MDA could be worth investigating further for growth investing!.
1. Profitability
1.1 Basic Checks
In the past year MDA was profitable.
MDA had a positive operating cash flow in the past year.
Of the past 5 years MDA 4 years were profitable.
MDA had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
With an excellent Return On Assets value of 3.15%, MDA belongs to the best of the industry, outperforming 81.82% of the companies in the same industry.
MDA has a better Return On Equity (8.24%) than 90.91% of its industry peers.
Looking at the Return On Invested Capital, with a value of 5.12%, MDA is in line with its industry, outperforming 45.45% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for MDA is below the industry average of 8.45%.
The last Return On Invested Capital (5.12%) for MDA is above the 3 year average (3.99%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 3.15% | ||
| ROE | 8.24% | ||
| ROIC | 5.12% |
ROA(3y)2.27%
ROA(5y)1.16%
ROE(3y)4.65%
ROE(5y)2.1%
ROIC(3y)3.99%
ROIC(5y)N/A
1.3 Margins
MDA's Profit Margin of 7.40% is amongst the best of the industry. MDA outperforms 90.91% of its industry peers.
MDA's Profit Margin has improved in the last couple of years.
MDA's Operating Margin of 9.86% is in line compared to the rest of the industry. MDA outperforms 45.45% of its industry peers.
MDA's Operating Margin has improved in the last couple of years.
MDA has a better Gross Margin (24.62%) than 72.73% of its industry peers.
MDA's Gross Margin has declined in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 9.86% | ||
| PM (TTM) | 7.4% | ||
| GM | 24.62% |
OM growth 3Y34.46%
OM growth 5YN/A
PM growth 3Y129.51%
PM growth 5YN/A
GM growth 3Y-9.5%
GM growth 5YN/A
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), MDA is destroying value.
MDA has more shares outstanding than it did 1 year ago.
Compared to 1 year ago, MDA has an improved debt to assets ratio.
2.2 Solvency
MDA has an Altman-Z score of 1.29. This is a bad value and indicates that MDA is not financially healthy and even has some risk of bankruptcy.
MDA's Altman-Z score of 1.29 is amongst the best of the industry. MDA outperforms 81.82% of its industry peers.
The Debt to FCF ratio of MDA is 0.92, which is an excellent value as it means it would take MDA, only 0.92 years of fcf income to pay off all of its debts.
The Debt to FCF ratio of MDA (0.92) is better than 100.00% of its industry peers.
MDA has a Debt/Equity ratio of 0.31. This is a healthy value indicating a solid balance between debt and equity.
Looking at the Debt to Equity ratio, with a value of 0.31, MDA belongs to the top of the industry, outperforming 81.82% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.31 | ||
| Debt/FCF | 0.92 | ||
| Altman-Z | 1.29 |
ROIC/WACC0.58
WACC8.78%
2.3 Liquidity
A Current Ratio of 0.55 indicates that MDA may have some problems paying its short term obligations.
MDA has a worse Current ratio (0.55) than 81.82% of its industry peers.
MDA has a Quick Ratio of 0.55. This is a bad value and indicates that MDA is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 0.54, MDA is in the better half of the industry, outperforming 63.64% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.55 | ||
| Quick Ratio | 0.54 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 98.25% over the past year.
MDA shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 185.75% yearly.
The Revenue has grown by 57.77% in the past year. This is a very strong growth!
The Revenue has been growing by 31.32% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)98.25%
EPS 3Y185.75%
EPS 5YN/A
EPS Q2Q%-16.67%
Revenue 1Y (TTM)57.77%
Revenue growth 3Y31.32%
Revenue growth 5YN/A
Sales Q2Q%45.11%
3.2 Future
MDA is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 35.31% yearly.
MDA is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 23.78% yearly.
EPS Next Y106.33%
EPS Next 2Y49.18%
EPS Next 3Y35.31%
EPS Next 5YN/A
Revenue Next Year52.26%
Revenue Next 2Y30.25%
Revenue Next 3Y23.78%
Revenue Next 5YN/A
3.3 Evolution
The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings ratio is 21.60, which indicates a rather expensive current valuation of MDA.
Compared to the rest of the industry, the Price/Earnings ratio of MDA indicates a somewhat cheap valuation: MDA is cheaper than 63.64% of the companies listed in the same industry.
The average S&P500 Price/Earnings ratio is at 26.28. MDA is around the same levels.
The Price/Forward Earnings ratio is 15.67, which indicates a correct valuation of MDA.
MDA's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. MDA is cheaper than 63.64% of the companies in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 23.52, MDA is valued a bit cheaper.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 21.6 | ||
| Fwd PE | 15.67 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, MDA is valued a bit cheaper than 63.64% of the companies in the same industry.
72.73% of the companies in the same industry are more expensive than MDA, based on the Price/Free Cash Flow ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 6.61 | ||
| EV/EBITDA | 12.54 |
4.3 Compensation for Growth
The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
The decent profitability rating of MDA may justify a higher PE ratio.
MDA's earnings are expected to grow with 35.31% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.2
PEG (5Y)N/A
EPS Next 2Y49.18%
EPS Next 3Y35.31%
5. Dividend
5.1 Amount
No dividends for MDA!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
TSX:MDA (12/8/2025, 7:00:00 PM)
24.41
-0.49 (-1.97%)
Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryAerospace & Defense
Earnings (Last)
Earnings (Next)
Inst Owners38.36%
Inst Owner ChangeN/A
Ins Owners1.17%
Ins Owner ChangeN/A
Market Cap3.08B
Revenue(TTM)1.48B
Net Income(TTM)109.60M
Analysts78.33
Price Target39.46 (61.66%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-9.07%
Min EPS beat(2)-40.3%
Max EPS beat(2)22.16%
EPS beat(4)3
Avg EPS beat(4)5.53%
Min EPS beat(4)-40.3%
Max EPS beat(4)22.16%
EPS beat(8)6
Avg EPS beat(8)21.97%
EPS beat(12)10
Avg EPS beat(12)31.49%
EPS beat(16)13
Avg EPS beat(16)66.41%
Revenue beat(2)1
Avg Revenue beat(2)0.06%
Min Revenue beat(2)-0.24%
Max Revenue beat(2)0.35%
Revenue beat(4)3
Avg Revenue beat(4)3.66%
Min Revenue beat(4)-0.24%
Max Revenue beat(4)7.65%
Revenue beat(8)5
Avg Revenue beat(8)2.65%
Revenue beat(12)9
Avg Revenue beat(12)2.56%
Revenue beat(16)11
Avg Revenue beat(16)1.78%
PT rev (1m)-11.19%
PT rev (3m)-24.77%
EPS NQ rev (1m)0.85%
EPS NQ rev (3m)-6%
EPS NY rev (1m)-0.69%
EPS NY rev (3m)-2.72%
Revenue NQ rev (1m)-0.89%
Revenue NQ rev (3m)-3.38%
Revenue NY rev (1m)0.12%
Revenue NY rev (3m)-0.74%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 21.6 | ||
| Fwd PE | 15.67 | ||
| P/S | 2.08 | ||
| P/FCF | 6.61 | ||
| P/OCF | 4.19 | ||
| P/B | 2.32 | ||
| P/tB | N/A | ||
| EV/EBITDA | 12.54 |
EPS(TTM)1.13
EY4.63%
EPS(NY)1.56
Fwd EY6.38%
FCF(TTM)3.69
FCFY15.13%
OCF(TTM)5.82
OCFY23.86%
SpS11.72
BVpS10.52
TBVpS-2.82
PEG (NY)0.2
PEG (5Y)N/A
Graham Number16.36
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 3.15% | ||
| ROE | 8.24% | ||
| ROCE | 7.1% | ||
| ROIC | 5.12% | ||
| ROICexc | 5.66% | ||
| ROICexgc | 60.4% | ||
| OM | 9.86% | ||
| PM (TTM) | 7.4% | ||
| GM | 24.62% | ||
| FCFM | 31.5% |
ROA(3y)2.27%
ROA(5y)1.16%
ROE(3y)4.65%
ROE(5y)2.1%
ROIC(3y)3.99%
ROIC(5y)N/A
ROICexc(3y)4.25%
ROICexc(5y)N/A
ROICexgc(3y)14.8%
ROICexgc(5y)N/A
ROCE(3y)5.54%
ROCE(5y)N/A
ROICexgc growth 3Y59.28%
ROICexgc growth 5YN/A
ROICexc growth 3Y71.38%
ROICexc growth 5YN/A
OM growth 3Y34.46%
OM growth 5YN/A
PM growth 3Y129.51%
PM growth 5YN/A
GM growth 3Y-9.5%
GM growth 5YN/A
F-Score6
Asset Turnover0.43
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.31 | ||
| Debt/FCF | 0.92 | ||
| Debt/EBITDA | 1.55 | ||
| Cap/Depr | 226.87% | ||
| Cap/Sales | 18.19% | ||
| Interest Coverage | 9.36 | ||
| Cash Conversion | 277.94% | ||
| Profit Quality | 425.55% | ||
| Current Ratio | 0.55 | ||
| Quick Ratio | 0.54 | ||
| Altman-Z | 1.29 |
F-Score6
WACC8.78%
ROIC/WACC0.58
Cap/Depr(3y)234.8%
Cap/Depr(5y)169.15%
Cap/Sales(3y)23.53%
Cap/Sales(5y)18.99%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)98.25%
EPS 3Y185.75%
EPS 5YN/A
EPS Q2Q%-16.67%
EPS Next Y106.33%
EPS Next 2Y49.18%
EPS Next 3Y35.31%
EPS Next 5YN/A
Revenue 1Y (TTM)57.77%
Revenue growth 3Y31.32%
Revenue growth 5YN/A
Sales Q2Q%45.11%
Revenue Next Year52.26%
Revenue Next 2Y30.25%
Revenue Next 3Y23.78%
Revenue Next 5YN/A
EBIT growth 1Y64.41%
EBIT growth 3Y76.57%
EBIT growth 5YN/A
EBIT Next Year182.28%
EBIT Next 3Y51.82%
EBIT Next 5YN/A
FCF growth 1Y631.81%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y674.42%
OCF growth 3Y124.48%
OCF growth 5YN/A
MDA SPACE LTD / MDA.CA FAQ
What is the fundamental rating for MDA stock?
ChartMill assigns a fundamental rating of 6 / 10 to MDA.CA.
What is the valuation status for MDA stock?
ChartMill assigns a valuation rating of 6 / 10 to MDA SPACE LTD (MDA.CA). This can be considered as Fairly Valued.
What is the profitability of MDA stock?
MDA SPACE LTD (MDA.CA) has a profitability rating of 7 / 10.
What is the valuation of MDA SPACE LTD based on its PE and PB ratios?
The Price/Earnings (PE) ratio for MDA SPACE LTD (MDA.CA) is 21.6 and the Price/Book (PB) ratio is 2.32.